Company

Shenzhen Kangtai Biological Products Co. Ltd

Headquarters: Shenzhen, China

Employees: 2,043

SZSE: 300601 -1.74%

Market Cap

CN¥16.80 Billion

CNY as of July 1, 2024

US$2.31 Billion

Market Cap History

Shenzhen Kangtai Biological Products Co. Ltd market capitalization over time

Evolution of Shenzhen Kangtai Biological Products Co. Ltd market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of Shenzhen Kangtai Biological Products Co. Ltd

Detailed Description

Shenzhen Kangtai Biological Products Co., Ltd. researches, develops, produces, and sells various types of human vaccines in China. The company's products include cell-free whitebait b-type haemophilus influenzae combined vaccine, SARS-COV-2 vaccine, recombinant hepatitis B vaccine, 23-valent pneumococcal polysaccharide vaccine, diphtheria tetanus acellular pertussis and haemophilus influenzae type b combined vaccine, haemophilus influenzae type b conjugate vaccine, measles and rubella combined with live attenuated vaccine, 13-valent pneumococcal conjugate vaccine, rabies vaccine, inactivated poliomyelitis vaccine, and HIB conjugate vaccine. It has an agreement between YTB and Yong Tai Berhad in relation to the development and commercialization of Covid-19 inactivated vaccine in Malaysia. Shenzhen Kangtai Biological Products Co., Ltd. was founded in 1992 and is based in Shenzhen, China.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Stocks & Indices

Shenzhen Kangtai Biological Products Co. Ltd has the following listings and related stock indices.


Stock: SZSE: 300601 wb_incandescent

Details

Headquarters:

No. 6, Kefa Road

Nanshan District

Shenzhen, None

China

Phone: 86 755 2698 8688

Fax: 86 755 2698 8600